Welcome to the latest edition of DNA Dispatch, the quarterly newsletter from OGT, your hybridization experts.
OGT is pleased to introduce the SureSeq™ Myeloid Fusion Panel, expanding your ability to identify key fusion genes implicated in AML and enhancing the understanding of myeloid cancer classification and progression.
Developed by scientists, for scientists, OGT understands the real-world application of our FISH portfolio.
Our CytoCell® range includes over 150 FISH probes our popular hematology FISH probes:
Discover the importance of detecting genetic variations in our CytoSure® whitepaper!
Highlighting the crucial role of identifying genetic changes, like Copy Number Variation (CNV) and Loss of Heterozygosity (LOH), in studying developmental disorders.
At OGT, we develop pioneering hybridization technology that fits seamlessly into your workflows.
Leveraging rational, expert-driven development, our SureSeq myeloid range offers enhanced detection of complex structural variants, better coverage uniformity and a clearer genetic profile of your samples.
Dive into our discussion on the development and current state of sequencing technologies, and where the future of NGS may take us.
Don’t forget…Our FAS team can be contacted online with free support advice
Visit International site
Visit USA site
International
